Model Medicines
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1268 Prospect St, La Jolla, California, ...Phone Number
(732) 423-2763Website
www.modelmedicines.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Model Medicines
Founded in 2019 and headquartered in La Jolla, United States, Model Medicines is an AI/ML Drug discovery company that reduces the time to bring a drug to market and the cost to bring a drug to market.Explore more
Model Medicines Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Model Medicines your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Model Medicines launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Model Medicines is spiking on competitors!
Funding: Get notified immidiatlly once Model Medicines has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Model Medicines had a recent Job posting/layoffs
Check if Model Medicines has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Model Medicines
Earning: See what the market has to say on Model Medicines recently announced quarterly report
Model Medicines, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Model Medicines
Compare insights from companies similar to Model Medicines, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Model Medicines
<$5M
1-10
Private
<$5M
2019
TU
Tyler UmanskySenior Manager, Machine Learning Head of Platform
Company Profile Activity
Activity Insights
Model Medicines is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Model Medicines is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Model Medicines.
Model Medicines financials insights
Gather financial insights about Model Medicines, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$4.1M
Model Medicines Tech Stack
A closer look at the technologies used by Model Medicines
Model Medicines News & Media
Model Medicines Appoints Dr. Launa Aspeslet as Senior Scientific & Clinical Advisor
Tenured Life Sciences Executive Joins AI-Driven Drug Discovery Company to Provide Strategic Guidance and Support Pipeline Growth LA JOLLA, Calif., April 24, 2024 /PRNewswire/ -- Model Medicines, a leading human health company specializing in generative AI-driven drug discovery, today...Model Medicines Unveils Groundbreaking AI Drug Discovery Advances in New Chemistry and New Biology with Two New Preprint Papers
LA JOLLA, Calif., April 9, 2024 /PRNewswire/ -- Model Medicines, a leading human health company specializing in generative AI-driven drug discovery, today announced the publication of two significant preprint papers on bioRxiv detailing major advances in antiviral and oncology drug...Model Medicines Discovers New Pan-Antiviral Chemical Entity (NCE) Library, Achieving Unprecedented 66.7% Hit Rate Using Proprietary AI Platform
LA JOLLA, Calif., March 20, 2024 /PRNewswire/ -- Model Medicines, a leading human health company specializing in generative AI-driven drug discovery, today announced groundbreaking headline results for the creation of a validated NCE, pan-antiviral library. By leveraging proprietary AI...Model Medicines Announces Launch of Oncology Programs with Multiple AI-Discovered Compounds Demonstrating Drug-Like Activity for Two High Value, Difficult to Drug, Oncogenic and Epigenetic Targets
AXL and BRD4 are highly biologically relevant oncogenic and epigenetic targets, respectively, implicated in numerous indications including both hematological and solid malignancies, but have historically been very challenging to drug. Model Medicine's Galileo™ Platform has discovered...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Model Medicines
Sign Up For FreeTo access detailed company insights
Founded in 2019 and headquartered in La Jolla, United States, Model Medicines is an AI/ML Drug discovery company that reduces the time to bring a drug to market and the cost to bring a drug to market.... Read More
